InTouch Health® unveiled today the RP-Xpress™ at the American Telemedicine Association's 16th Annual International Meeting and Exposition in Tampa, FL. The RP-Xpress™ is a portable telemedicine device designed for use in clinical environments using standard 802.11 Wi-Fi, enabling physicians to deliver real-time patient consults into hospitals and clinics. InTouch Health and select health system partners are further developing 'out of hospital' telemedicine applications with RP-Xpress utilizing cellular broadband connectivity.
RP-Xpress is a lightweight, rugged, portable device that brings the physician to the point of care, enabling remote consultation and active patient monitoring. As with all InTouch Health Remote Presence telemedicine devices, the RP-Xpress is FDA-cleared Class II for the highest level of clinical acuity. The portability of the RP-Xpress enables the delivery of clinical services across the continuum of care, improving the quality, access and timeliness of care.
"I envision the RP-Xpress being used in a variety of clinical environments, where the portability of the device will lend to earlier subspecialist consultation with an extra set of eyes and ears on the patient. In the case of transport, the RP-Xpress will allow me to assess a patient and recommend treatment strategies hours earlier than I would otherwise. For a critically ill pediatric patient, the management during those first few hours clearly influence outcome," stated Dr. Jason Knight, Medical Director of Emergency Transport Services at Children's Hospital of Orange County, California.
InTouch Health provides complete telemedicine solutions that allow physicians to remotely perform real-time consults with hospital patients. The Company provides a secure cloud-based telemedicine platform, FDA-cleared Remote Presence devices, 24/7 network support and comprehensive planning and implementation services.
InTouch Health is showcasing its complete suite of telemedicine products and services at the American Telemedicine Association annual conference in Tampa, FL, May 1- 3, 2011.
U.S. cancer detection severely disrupted during first year of COVID-19, shows incomplete recovery in second year